Skip to main navigation Skip to search Skip to main content

Characterisation of age and polarity at onset in bipolar disorder

  • Janos L. Kalman*
  • , Loes M.Olde Loohuis
  • , Annabel Vreeker
  • , Andrew McQuillin
  • , Eli A. Stahl
  • , Douglas Ruderfer
  • , Maria Grigoroiu-Serbanescu
  • , Georgia Panagiotaropoulou
  • , Stephan Ripke
  • , Tim B. Bigdeli
  • , Frederike Stein
  • , Tina Meller
  • , Susanne Meinert
  • , Helena Pelin
  • , Fabian Streit
  • , Sergi Papiol
  • , Mark J. Adams
  • , Rolf Adolfsson
  • , Kristina Adorjan
  • , Ingrid Agartz
  • Sofie R. Aminoff, Heike Anderson-Schmidt, Ole A. Andreassen, Raffaella Ardau, Jean Michel Aubry, Ceylan Balaban, Nicholas Bass, Bernhard T. Baune, Frank Bellivier, Antoni Benabarre, Susanne Bengesser, Wade H. Berrettini, Marco P. Boks, Evelyn J. Bromet, Katharina Brosch, Monika Budde, William Byerley, Pablo Cervantes, Catina Chillotti, Sven Cichon, Scott R. Clark, Ashley L. Comes, Aiden Corvin, William Coryell, Nick Craddock, David W. Craig, Paul E. Croarkin, Cristiana Cruceanu, Piotr M. Czerski, Nina Dalkner, Udo Dannlowski, Franziska Degenhardt, Maria Del Zompo, J. Raymond Depaulo, Srdjan Djurovic, Howard J. Edenberg, Mariam Al Eissa, Torbjorn Elvsåshagen, Bruno Etain, Ayman H. Fanous, Frederike Fellendorf, Alessia Fiorentino, Andreas J. Forstner, Mark A. Frye, Janice M. Fullerton, Katrin Gade, Julie Garnham, Elliot Gershon, Michael Gill, Fernando S. Goes, Katherine Gordon-Smith, Paul Grof, Jose Guzman-Parra, Tim Hahn, Roland Hasler, Maria Heilbronner, Urs Heilbronner, Stephane Jamain, Esther Jimenez, Ian Jones, Lisa Jones, Lina Jonsson, Rene S. Kahn, John R. Kelsoe, James L. Kennedy, Tilo Kircher, George Kirov, Sarah Kittel-Schneider, Farah Klöhn-Saghatolislam, James A. Knowles, Thorsten M. Kranz, Trine Vik Lagerberg, Mikael Landen, William B. Lawson, Marion Leboyer, Qingqin S. Li, Mario Maj, Dolores Malaspina, Mirko Manchia, Fermin Mayoral, Susan L. McElroy, Melvin G. McInnis, Andrew M. McIntosh, Helena Medeiros, Ingrid Melle, Vihra Milanova, Philip B. Mitchell, Palmiero Monteleone, Alessio Maria Monteleone, Markus M. Nöthen, Tomas Novak, John I. Nurnberger, Niamh O'Brien, Kevin S. O'Connell, Claire O'Donovan, Michael C. O'Donovan, Nils Opel, Abigail Ortiz, Michael J. Owen, Erik Pålsson, Carlos Pato, Michele T. Pato, Joanna Pawlak, Julia Katharina Pfarr, Claudia Pisanu, James B. Potash, Mark H. Rapaport, Daniela Reich-Erkelenz, Andreas Reif, Eva Reininghaus, Jonathan Repple, Hélène Richard-Lepouriel, Marcella Rietschel, Kai Ringwald, Gloria Roberts, Guy Rouleau, Sabrina Schaupp, William A. Scheftner, Simon Schmitt, Peter R. Schofield, K. Oliver Schubert, Eva C. Schulte, Barbara Schweizer, Fanny Senner, Giovanni Severino, Sally Sharp, Claire Slaney, Olav B. Smeland, Janet L. Sobell, Alessio Squassina, Pavla Stopkova, John Strauss, Alfonso Tortorella, Gustavo Turecki, Joanna Twarowska-Hauser, Marin Veldic, Eduard Vieta, John B. Vincent, Wei Xu, Clement C. Zai, Peter P. Zandi, Arianna Di Florio, Jordan W. Smoller, Joanna M. Biernacka, Francis J. McMahon, Martin Alda, Bertram Müller-Myhsok, Nikolaos Koutsouleris, Peter Falkai, Nelson B. Freimer, Till F.M. Andlauer, Thomas G. Schulze, Roel A. Ophoff
*Corresponding author for this work
  • Klinikum der Universität München
  • International Max Planck Research School for Translational Psychiatry
  • Semel Institute for Neuroscience and Human Behavior
  • University College London
  • Icahn School of Medicine at Mount Sinai
  • Vanderbilt University School of Medicine
  • Alexandru Obregia Clinical Psychiatric Hospital
  • Charité – Universitätsmedizin Berlin
  • Massachusetts General Hospital
  • Broad Institute of MIT and Harvard
  • State University of New York (SUNY)
  • Department of Veterans Affairs
  • Universität Marburg
  • Centre for Mind, Brain and Behavior (CMBB)
  • University of Münster
  • Max Planck Institute of Psychiatry
  • Heidelberg University 
  • Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)
  • University of Edinburgh
  • Umeå University
  • Karolinska Institutet
  • Diakonhjemmet Hospital
  • University of Oslo
  • Oslo University Hospital
  • University of Göttingen
  • University Hospital Agency of Cagliari
  • University of Geneva Medical School
  • University Hospital Frankfurt am Main
  • University of Melbourne
  • Adelaide Medical School
  • Université Paris Cité
  • Institut national de la santé et de la recherche médicale
  • Assistance publique – Hôpitaux de Paris
  • University of Barcelona
  • Medical University of Graz
  • University of Pennsylvania
  • University Medical Centre Utrecht
  • Stony Brook University
  • University of California at San Francisco
  • McGill University
  • University of Basel
  • University Hospital Bonn
  • Universitätsspital Basel
  • Jülich Research Centre
  • University of Adelaide
  • Bazil Hetzel Institute
  • St. James’s Hospital
  • University of Iowa
  • Cardiff University
  • USC
  • Mayo Clinic Rochester, MN
  • University of Medical Sciences Poznan
  • University of Bonn
  • University Hospital Essen
  • University of Cagliari
  • Johns Hopkins University
  • Oslo University Hospital-Ullevål
  • Bergen University Medical School
  • Indiana University School of Medicine
  • Neuroscience Research Australia
  • University of New South Wales
  • Nova Scotia Health Authority
  • The University of Chicago
  • University of Worcester
  • Mood Disorders Centre of Ottawa
  • University of Toronto
  • University Regional Hospital
  • Université Paris-Est Créteil
  • Neuropsychiatrie Translationnelle
  • The Sahlgrenska Academy at the University of Gothenburg
  • University of California at San Diego
  • Centre for Addiction and Mental Health (Toronto)
  • Psychosomatic Medicine and Psychotherapy
  • University Hospital Würzburg
  • Howard University
  • Janssen Research and Development, LLC
  • University of Campania Luigi Vanvitelli
  • Dalhousie University
  • Lindner Center of HOPE
  • University of Michigan, Ann Arbor
  • Alexander University Hospital
  • University of Salerno
  • National Institute of Mental Health (Czech rep.)
  • Emory University
  • University Hospital of Geneva
  • Montreal Neurological Institute
  • Rush University
  • SA Health
  • University of Southern California
  • King's College London
  • University of Perugia
  • Harvard T.H. Chan School of Public Health
  • Center for Genomic Medicine
  • National Institutes of Mental Health - U.S.A.
  • University of California at Los Angeles
  • Klinikum rechts der Isar der Technischen Universität München
  • Johns Hopkins School of Medicine
  • SUNY Upstate Medical University

Research output: Contribution to journalArticleAcademicpeer-review

42 Citations (Scopus)
97 Downloads (Pure)

Abstract

Background Studying phenotypic and genetic characteristics of age at onset (AAO) and polarity at onset (PAO) in bipolar disorder can provide new insights into disease pathology and facilitate the development of screening tools. Aims To examine the genetic architecture of AAO and PAO and their association with bipolar disorder disease characteristics. Method Genome-wide association studies (GWASs) and polygenic score (PGS) analyses of AAO (n = 12 977) and PAO (n = 6773) were conducted in patients with bipolar disorder from 34 cohorts and a replication sample (n = 2237). The association of onset with disease characteristics was investigated in two of these cohorts. Results Earlier AAO was associated with a higher probability of psychotic symptoms, suicidality, lower educational attainment, not living together and fewer episodes. Depressive onset correlated with suicidality and manic onset correlated with delusions and manic episodes. Systematic differences in AAO between cohorts and continents of origin were observed. This was also reflected in single-nucleotide variant-based heritability estimates, with higher heritabilities for stricter onset definitions. Increased PGS for autism spectrum disorder (β = -0.34 years, s.e. = 0.08), major depression (β = -0.34 years, s.e. = 0.08), schizophrenia (β = -0.39 years, s.e. = 0.08), and educational attainment (β = -0.31 years, s.e. = 0.08) were associated with an earlier AAO. The AAO GWAS identified one significant locus, but this finding did not replicate. Neither GWAS nor PGS analyses yielded significant associations with PAO. Conclusions AAO and PAO are associated with indicators of bipolar disorder severity. Individuals with an earlier onset show an increased polygenic liability for a broad spectrum of psychiatric traits. Systematic differences in AAO across cohorts, continents and phenotype definitions introduce significant heterogeneity, affecting analyses.

Original languageEnglish
Pages (from-to)659-669
Number of pages11
JournalBritish Journal of Psychiatry
Volume219
Issue number6
DOIs
Publication statusPublished - 11 Dec 2021

Bibliographical note

Funding Information:
Amare T. Azmeraw: has received 2020–2022 NARSAD Young Investigator Grant from the Brain & Behaviour Research Foundation. Ole A. Andreassen: speaker’s honorarium Sunovion, Lundbeck. Consultant HealthLytix. Bernhard Baune: Honoraria: Lundbeck, Janssen, LivaNova, Servier. Carrie Bearden: Novartis Scientific Advisory Board. Clark Scott: Honoraria and Investigator-initiated project funding from Jannsen-Cilag Australia, Lundbeck-Otsuka Australia. J. Raymond DePaulo: owns stock in CVS Health; JRD was unpaid consultant for Myriad Neuroscience 2017 & 2019. Michael C. O´Donovan: research unrelated to this manuscript supported by a collaborative research grant from Takeda Pharmaceuticals. Bruno Etain: honoraria for Sanofi. Mark A. Frye: grant Support Assurex Health, Mayo Foundation, Medibio Consultant (Mayo) Actify Neurotherapies, Allergan, Intra-Cellular Therapies, Inc., Janssen, Myriad, Neuralstem Inc., Sanofi, Takeda, Teva Pharmaceuticals. Per Hoffmann: employee of Life&Brain GmbH, Member of the Scientific Advisory Board of HMG Systems Engeneering GmbH. Mikael Landen: Speaker’s honoraria Lundbeck pharmaceuticals. Andrew M McIntosh: research funding from The Sackler Trust, speaker fees from Illumina and Janssen. Philip B. Mitchell: remuneration for lectures in China on bipolar disorder research by Sanofi (Hangzhou). John Nurnberger: investigator for Janssen. Benjamin M. Neale: is a member of the scientific advisory board at Deep Genomics and RBNC Therapeutics. A consultant for Camp4 Therapeutics, Takeda Pharmaceutical and Biogen. Andreas Reif: apeaker’s honoraria / Advisory boards: Janssen, Shire/Takeda, Medice, SAGE and Servier. Eli Stahl: now employed by the Regeneron Genetics Center. Kato Tadafumi: honoraria: Kyowa Hakko Kirin Co., Ltd., Eli Lilly Japan K.K., Otsuka Pharmaceutical Co., Ltd., GlaxoSmithKline K.K., Taisho Pharma Co., Ltd., Taisho Pharmaceutical Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Meiji Seika Pharma Co., Ltd., Pfizer Japan Inc., Mochida Pharmaceutical Co., Ltd., Shionogi & Co., Ltd., Janssen Pharmaceutical K.K., Janssen Asia Pacific, Yoshitomiyakuhin, Astellas Pharma Inc., Nippon, Boehringer Ingelheim Co. Ltd., MSD K.K., Kyowa Pharmaceutical Industry Co., Ltd., Takeda Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Eisai Co., Ltd. Grants: Takeda Pharmaceutical Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Shionogi & Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation. Thomas G. Schulze: is a member of the editorial board of The British Journal of Psychiatry. He did not take part in the review or decision-making process of this paper. Eduard Vieta: has received grants and served as consultant, advisor or CME speaker for the following entities: AB-Biotics, Abbott, Allergan, Angelini, Dainippon Sumitomo Pharma, Ferrer, Gedeon Richter, Janssen, Lundbeck, Otsuka, Sage, Sanofi-Aventis, Sunovion and Takeda. None of the other authors reported any biomedical financial interests or potential conflicts of interest. ICMJE forms are in the supplementary material, available online at https://doi.org/10.1192/10.1192/bjp.2021.102.

Publisher Copyright:
Copyright © The Author(s), 2021.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Characterisation of age and polarity at onset in bipolar disorder'. Together they form a unique fingerprint.

Cite this